Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,188
Out of 5,143 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $28.65 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $75.35 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $245.25 | +30.48% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $96.75 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $31.14 | +54.14% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $175.35 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $1.85 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Holdings | Upgrades: Buy | $80 | $137.10 | -41.65% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $9.65 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $103.45 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $114.58 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $75.15 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $73.09 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $82.40 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $28.65
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $75.35
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $245.25
Upside: +30.48%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $96.75
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $31.14
Upside: +54.14%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $175.35
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $1.85
Upside: -
iRhythm Holdings
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $137.10
Upside: -41.65%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $9.65
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $103.45
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $114.58
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $75.15
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $73.09
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $82.40
Upside: -